Heyman Tomas J.

CIK 00018146736 companiesALAMEDA, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001814673

Recent Transactions

34 trades

Award
EXELIXIS, INC.$EXEL
Common Stock
2026-05-27+8,367→ 50,649 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−26,000→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−13,000→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−15,000→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−15,000→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Common Stock
2025-12-09−9,398→ 0 total
Award
Akero Therapeutics, Inc.
Common Stock
2025-06-03+9,398→ 9,398 total
Award
EXELIXIS, INC.$EXEL
Common Stock
2025-05-29+9,812→ 42,282 total
Disposition to Issuer
OptiNose, Inc.
Stock Option (Right to Buy)
2025-05-21−962→ 0 total
Sale
EXELIXIS, INC.$EXEL
Common Stock
2025-05-21$44.29/sh−4,544→ 32,470 total
Disposition to Issuer
OptiNose, Inc.
Stock Option (Right to Buy)
2025-05-21−1,925→ 0 total
Disposition to Issuer
OptiNose, Inc.
Stock Option (Right to Buy)
2025-05-21−5,000→ 0 total
Disposition to Issuer
OptiNose, Inc.
Stock Option (Right to Buy)
2025-05-21−3,566→ 0 total
Disposition to Issuer
OptiNose, Inc.
Stock Option (Right to Buy)
2025-05-21−2,133→ 0 total
Award
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2024-06-08+26,000→ 26,000 total
Award
OptiNose, Inc.
Stock Option (Right to Buy)
2024-06-06+75,000→ 75,000 total
Award
EXELIXIS, INC.$EXEL
Common Stock
2024-05-31+18,838→ 37,014 total
Award
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2023-06-23+15,000→ 15,000 total
Exercise/Conversion
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2023-06-16−26,000→ 0 total
Sale
Akero Therapeutics, Inc.
Common Stock
2023-06-16$54.67/sh−26,000→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.
Common Stock
2023-06-16$25.04/sh+26,000→ 26,000 total
Award
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2023-06-12+13,200→ 13,200 total
Award
OptiNose, Inc.
Stock Option (Right to Buy)
2023-06-08+53,500→ 53,500 total
Award
EXELIXIS, INC.$EXEL
Common Stock
2023-05-31+18,176→ 18,176 total
Award
EXELIXIS, INC.$EXEL
Option (right to buy)
2023-05-31+36,353→ 36,353 total
Award
Invivyd, Inc.$IVVD
Stock Option (Right to Buy)
2023-05-23+50,000→ 50,000 total
Award
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2022-09-15+26,400→ 26,400 total
Award
Invivyd, Inc.$IVVD
Stock Option (Right to Buy)
2022-06-22+75,000→ 75,000 total
Award
OptiNose, Inc.
Stock Option (Right to Buy)
2022-06-08+32,000→ 32,000 total
Award
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2022-06-02+15,000→ 15,000 total
Award
OptiNose, Inc.
Stock Option (Right to Buy)
2021-06-09+14,439→ 14,439 total
Award
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2021-06-01+13,000→ 13,000 total
Award
OptiNose, Inc.
Stock Option (Right to Buy)
2020-12-01+28,879→ 28,879 total
Award
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2020-06-09−26,000→ 26,000 total

Companies

Recent Filings

Address

C/O EXELIXIS, INC. 1851 HARBOR BAY PARKWAY

ALAMEDA, CA, 94502

View on SEC.gov